PTC
DERM icon

Private Trust Company’s Journey Medical DERM Stock Holding History

Private Trust Company’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100
Closed -$590 – 2486
2025
Q1 		$590 Sell
100
-400
-80% -$1.97K ﹤0.01% 2415
2024
Q4 		$1.96K Hold
500
– – ﹤0.01% 2169
2024
Q3 		$2.83K Buy
+500
New +$2.58K ﹤0.01% 2109

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Private Trust Company's DERM Position: Q2 2025 in Review

Private Trust Company sold out of Journey Medical (DERM) in Q2 2025, closing a stake of 100 shares — an estimated $590 sold.

Private Trust Company first reported a position in DERM in Q3 2024 and held it in 3 quarters. The position peaked at $2.83K in Q3 2024. 56 funds tracked by Wall St. Rank hold DERM as of Q2 2025.

  • Private Trust Company reported no remaining Journey Medical position as of Q2 2025 after selling out during the quarter.
  • Private Trust Company sold 100 Journey Medical shares in Q2 2025, an estimated $590.
  • Private Trust Company first reported a position in Journey Medical in Q3 2024 and held it in 3 quarters.
  • Private Trust Company's Journey Medical position peaked at $2.83K in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Journey Medical as of Q2 2025.

Based on Private Trust Company's 13F filing for Q2 2025, filed 29 Jul 2025.